Can Google’s new anti-aging company, Calico, have you Googling at age 140? Don’t sell your burial plot just yet. The idea of anti-aging has been around for a very long time and efforts to combat aging have spanned millennia largely without any success so Calico (apparently short for California Life Company, which sounds more like an insurance company to me) faces long odds. Note too that Calico cats are not known for any particular predisposition to long life. Hmmm. At the same time, Calico …Read More
What’s the deal with this week’s FDA Warning Letter to 23andMe? First some background. I’m a researcher who studies stem and cancer cell genomics and epigenomics. I’m also a human being who has battled prostate cancer and is curious about my genome. With this background, I decided some time ago to take the plunge and experience what 23andMe has to offer in the way of personal genomics analysis. I thought of it as an experiment. I contacted them with my interest and background. We agreed to …Read More
I recently interviewed Drs. Elliot Lander and Mark Berman of the Cell Surgical Network, an affiliated chain of clinics selling stem cell interventions for more than a dozen medical conditions. You can read Part 1 here and Part 2 here of the interview where we cover 10 important questions. Today is Part 3, where I explain why their answers deeply trouble me. First, let me answer a question myself: why interview the leaders of the Cell Surgical Network, especially if I felt going into it that I would …Read More
The stem cell field has seen quite a few high-profile, intriguing papers on induced pluripotent stem (iPS) cells. Which do you think is the iPS cell paper of the year for 2013? The iPS cell field continues to advance rapidly. If you think one not listed is the best, let us know in the comments.